PSM’s Shabbir Imber Safdar speaks to Canadian patient advocate Durhane Wong-Rieger about the drug shortage situation in Canada.
Read MoreWhat drugs have states said they plan to export from Canada’s drug supply? We combed all their applications to the FDA and compiled that list into one document.
Read MoreFamily advocates Andrea Thomas and Amy Neville will distribute naloxone at the Dirksen Senate Office Building. The VA will use the NABP’s digital DSCSA platform to help with compliance. Guilty pleas for dark web drug trafficking and manufacturing fake oxycodone, and more.
Read MoreOn January 17, 2024 PSM wrote the Senate Subcommittee on Intellectual Property to endorse S.2934, which would expand the Trademark Act of 1946 to extend liability for selling harmful counterfeits to online platforms. Read the letter here.
Read MoreTests of the counterfeits showed that they were made of many substances, including acetaminophen, duloxetine, caffeine and methamphetamine. Overseas, authorities seized counterfeit pregabalin in Belfast. Pakistan recalled toxic cough syrup. Fake Xanax trafficker Ryan Farace got an additional sentence for money laundering. News about pill presses in five states.
Read MorePSM recently published contracts, some obtained via FOIA, with key vendors implementing Colorado’s and Florida’s Canadian drug importation plan. Read them here.
Read MoreFlorida’s October 20, 2023 SIP application is the second to last application before FDA approval. The final application was filed on November 16, 2023.
Read MoreHomeland Security seized over 1,800 pill presses in October and November 2023. The FDA warned Amazon not to sell supplements made with undeclared pharmaceuticals and issued another warning about toxic yellow oleander. More domestic and international news about counterfeit medicine.
Read MorePSM’s statement on the FDA decision and full coverage including media stories, official documents, and statements from stakeholders.
Read MoreFDA continues to investigate counterfeit Ozempic (semaglutide) injection 1 milligram (mg) in the legitimate U.S. drug supply chain and has seized thousands of units of the product. FDA is aware of five adverse events from this lot.
Read More